Projecting lifetime HIV-related healthcare costs for youth with HIV in the United States
We projected that US YHIV in care aged 13-24 years would incur nearly $17 billion in lifetime HIV-related healthcare costs. While total costs would increase with improved HIV-related care due to longer life expectancy, monthly costs would be highest during time spent at lower CD4 counts. ART costs would drive lifetime HIV-related healthcare costs for YHIV. Efforts to decrease ART prices and interventions to improve HIV care engagement and support consistent ART use could reduce HIV care costs and improve health outcomes for YHIV.
Authors
- Sarah E. Rutstein (ORCID: https://orcid.org/0000-0002-1571-6576)
- Maria Trent (ORCID: https://orcid.org/0000-0002-4973-5417)
- Allison L. Agwu (ORCID: https://orcid.org/0000-0002-8449-222X)
- Clare Flanagan (ORCID: https://orcid.org/0000-0002-2425-7690)
- Kunjal Patel (ORCID: https://orcid.org/0000-0003-0002-681X)
- Anne M. Neilan (ORCID: https://orcid.org/0000-0001-7915-4974)
- Emily P. Hyle (ORCID: https://orcid.org/0000-0001-8721-106X)
- John Giardina
- Andrea Ciaranello (ORCID: https://orcid.org/0000-0002-4268-3263)
- Michelle L. Jones (ORCID: https://orcid.org/0000-0002-2979-5527)
- Joshua Espada
- Kenneth A. Freedberg (ORCID: https://orcid.org/0000-0003-3143-7822)
- Sujata E. Tewari
Institutions
- Florida State University (US)
- University of North Carolina at Chapel Hill (US)
- Harvard University (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Massachusetts General Hospital (US)
- Cancer Research And Biostatistics (US)
- Johns Hopkins University Center for AIDS Research
Publication Details
- Journal
- BMC Health Services Research
- Published
- 2025-12-05
- DOI
- https://doi.org/10.1186/s12913-025-13757-8
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00